Streetbeat News

Stock Prices

KZIA

Kazia Therapeutics has been granted an additional 180 days by Nasdaq to regain compliance with the Minimum Bid Price Requirement. The company has until November 18, 2024, to ensure its stock price meets the $1.00 per share minimum for 10 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:14 am

TITN

Titan Machinery shares are trading lower after the company reported worse-than-expected Q1 earnings. The CEO has cautioned about soft demand and an excess of supply inventory.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:11 am

HLNE

Hamilton Lane (NASDAQ:HLNE) reported Q4 2024 adjusted EPS of $1.38, beating the $1.01 estimate by 36.63%. Sales were $176.665M, surpassing the $136.437M estimate by 29.48%. This represents a 43.75% increase in EPS and a 56.63% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:08 am

NVDA

NWSA

QQQ

SNOW

SPY

VFC

ZUO

Wall Street is set for a strong open driven by Nvidia's positive earnings, with key economic data and a Federal Reserve official's speech also in focus. Nvidia's stock surged over 6.6% in premarket trading, while other notable movements include Snowflake, V.F. Corporation, and Zuora. Analysts suggest a bullish near-term market outlook, but caution on the potential impact of weak economic data.

Portfolio Pulse from Shanthi Rexaline

May 23, 2024 | 11:07 am

CVAC

CureVac reported Q1 2024 sales of €12.400 million, surpassing the estimated €12.030 million.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:06 am

CLBT

Cellebrite DI (NASDAQ:CLBT) reported Q1 2024 earnings of $0.08 per share, beating the analyst estimate of $0.06 by 33.33%. Sales were $89.582 million, surpassing the $87.757 million estimate and marking a 25.76% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:03 am

FBTC

GBTC

IBIT

Bitcoin spot ETFs have seen significant inflows, totaling $154 million on May 22, with BlackRock's Bitcoin ETF (IBIT) and Fidelity's Bitcoin ETF (FBTC) leading the way. In contrast, Grayscale's Bitcoin Trust (GBTC) experienced outflows. Ethereum ETFs, however, have had a lukewarm reception, particularly in Hong Kong. The SEC's potential approval of an Ethereum ETF has sparked debate within the crypto community.

Portfolio Pulse from Murtuza Merchant

May 23, 2024 | 11:03 am

TNGX

Tango Therapeutics shares are trading lower after the company announced the discontinuation of its TNG348 program.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:02 am

TNGX

Tango Therapeutics has discontinued its TNG348 program due to Grade 3/4 liver function abnormalities observed in patients after eight weeks. The program was in a phase 1/2 clinical trial for BRCA1/2-mutant and HRD+ cancers. No patients had received the combination of TNG348 and olaparib.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:01 am

BMY

Bristol Myers Squibb (BMY) will present data on KarXT at the American Society of Clinical Psychopharmacology (ASCP) meeting from May 28-31.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 11:01 am